Hester Biosciences has announced the appointment of Ashish Desai as its new Chief Financial Officer, effective immediately. With over 25 years of experience in finance and leadership roles, Desai’s strategic expertise is expected to bolster the company's growth trajectory in the biotech sector.
-
Ashish Desai joins Hester Biosciences as the new CFO, bringing extensive experience in finance and corporate strategy.
-
Desai previously served as Group Chief Financial Officer at Ashapura Minechem Ltd., with a strong background in financial management and operations.
-
His appointment aims to strengthen Hester's financial planning, investor relations, and strategic initiatives.
-
Desai’s deep expertise in business development and governance will support Hester's growth in India and international markets.
-
The appointment aligns with Hester Biosciences’ focus on expanding its leadership team to accelerate growth and operational excellence.
Detailed Report
Hester Biosciences , a leading player in the veterinary pharmaceutical and biotech space in India, has appointed Ashish Desai as its new Chief Financial Officer effective immediately. With over 25 years of experience, Desai has a proven track record in financial management, business planning, and strategic growth.
Desai has previously held key leadership roles, including Group CFO at Ashapura Minechem Ltd., where he managed financial operations, investor relations, and strategic planning. His appointment at Hester Biosciences is expected to reinforce the company’s financial discipline and support its ongoing expansion efforts, both domestically and internationally.
This move signifies Hester's commitment to strengthening its leadership and creating a robust financial strategy to bolster its position in the animal health and biotech sectors. Investors and stakeholders anticipate that Desai's expertise will help navigate the evolving industry landscape and unlock new growth opportunities.
Source: NSE India, LinkedIn, Business Standard